MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
©2003 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
1,1-Disubstituted Tetrahydroisoquinolines
3031
4d: Anal. calcd. for C21H25NO4: C 70.96, H 7.09, N 3.94%; found: C
70.90, H 7.12, N 3.87%; 1H-NMR: 1.06 (t, 3H, J ¼ 7.1), 2.61–3.06
(m, 5H), 3.18 (s, 2H), 3.79 (s, 3H), 3.87 (s, 3H), 3.97 (q, 2H, J ¼ 7.1),
6.61 (s, 1H), 6.63 (s, 1H), 7.20–7.34 (m, 5H); 13C-NMR 13.6, 30.3, 42.5,
49.1, 53.9, 55.8, 56.0, 61.5, 109.0, 114.2, 126.2, 127.9, 129.9, 131.5, 134.6,
146.5, 148.1, 171.2.
4e: Anal. calcd. for C14H20N2O3: C 63.62, H 7.63, N 10.60%; found:
C 63.73, H 7.72, N 10.74%; 1H-NMR (DMSO-d6): 1.34 (s, 3H), 2.35 (d,
1H, J ¼ 14.3), 2.49–2.57 (m, 2H), 2.62 (d, 1H, J ¼ 14.3), 2.85–2.99 (m,
2H), 3.32 (br s, 1H), 3.69 (s, 3H), 3.71 (s, 3H), 6.57 (s, 1H), 6.74 (s, 1H),
7.74 (s, 2H); 13C-NMR: 28.5, 30.4, 39.5, 47.3, 54.3, 55.8, 56.1, 111.8,
113.9, 129.0, 137.7, 147.8, 148.0, 172.5.
4f: Anal. calcd. for C20H24N2O3: C 70.57, H 7.11, N 8.23%; found:
1
C 70.62, H 7.19, N 8.37%; H-NMR: 1.54 (s, 3H), 1.76 (br s, 1H), 2.56
(d, 1H, J ¼ 15.9), 2.73–2.80 (m, 2H), 2.94 (d, 1H, J ¼ 15.9), 3.15–3.29
(m, 2H), 3.81 (s, 3H), 3.83 (s, 3H), 6.52 (s, 1H), 6.67 (s, 1H), 7.02–7.49
(m, 5H), 11.15 (s, 1H); 13C-NMR: 29.0, 29.4, 38.3, 48.0, 54.5, 55.6, 55.9,
108.5, 111.4, 119.6, 123.4, 125.9, 128.7, 132.7, 138.3, 147.4, 147.5, 169.1.
4g: Anal. calcd. for C20H23N3O5: C 62.33, H 6.02, N 10.90%; found:
1
C 62.49, H 5.91, N 10.63%; H-NMR: 1.57 (s, 3H), 1.69 (br s, 1H), 2.63
(d, 1H, J ¼ 16.0), 2.71–2.90 (m, 2H), 2.98 (d, 1H, J ¼ 16.0), 3.16–3.38
(m, 2H), 3.82 (s, 3H), 3.86 (s, 3H), 6.53 (s, 1H), 6.66 (s, 1H), 7.58–7.65
(m, 2H), 8.12–8.18 (m, 2H), 11.88 (s, 1H); 13C-NMR: 29.2, 29.5, 39.2,
48.2, 54.9, 55.9, 56.1, 109.0, 111.8, 121.5, 125.9, 129.3, 137.8, 138.4, 144.5,
147.4, 147.5, 170.0.
4h: Anal. calcd. for C17H21N3O3S: C 58.77, H 6.09, N 12.09%;
1
found: C 58.90, H 6.18, N 12.31%; H-NMR: 1.56 (s, 3H), 2.67 (d,
1H, J ¼ 16.1), 2.73–2.90 (m, 2H), 3.03 (d, 1H, J ¼ 16.1), 3.12–3.35 (m,
2H), 3.82 (s, 3H), 3.84 (s, 3H), 6.53 (s, 1H), 6.65 (s, 1H), 6.89 (d, 1H,
J ¼ 3.6), 7.40 (d, 1H, J ¼ 3.6), 12.10 (br s, 1H); 13C-NMR: 29.0, 29.3,
38.3, 46.5, 54.5, 55.7, 56.0, 108.4, 111.5, 113.0, 126.2, 132.0, 137.3,
147.6, 157.9, 168.6.
4i: Anal. calcd. for C18H28N2O3: C 67.47, H 8.81, N 8.74%;
1
found: C 67.38, H 8.95, N 8.52%; H-NMR: 1.04 (t, 3H, J ¼ 7.1), 1.16
(t, 3H, J ¼ 7.1), 1.53 (s, 3H), 2.62 (d, 1H, J ¼ 15.5), 2.72–2.77 (m, 2H),
2.88 (d, 1H, J ¼ 15.5), 3.03–3.15 (m, 5H), 3.84 (s, 3H), 3.85 (s, 3H), 6.57
(s, 1H), 6.62 (s, 1H); 13C-NMR: 12.8, 14.2, 29.0, 29.6, 38.6, 39.9, 41.9,
42.1, 54.9, 55.5, 56.0, 108.8, 111.6, 127.5, 134.6, 146.8, 147.0, 170.1.
Hexahydropyrimido[6,1-a]isoquinolin-2-ones (6) - General procedure.
36% aqueous H2CO (1.1 mmol) and anhydrous Na2SO4 (300 mg) were
added to a solution of the corresponding 1,1-disubstituted tetrahydro-
isoquinoline (1 mmol) in 5 mL dichloromethane (or acetonitrile for 4e).